U.S. Tobacco Stock News

ATN International stock surged 27.6% to US$30.63 today, and the market is treating this quarter as a clean break from the past. The emotional trigger is simple. A telecom that had been grinding through modest revenue shifts just reported quarterly basic earnings per share of US$10.87 and trailing basic earnings per share of US$10.42, heavily shaped by a large non recurring gain from its United States tower sale. The question now is whether that one time windfall justifies such a sharp...

Exelixis stock just gave investors a jolt. The shares closed down almost 8% at US$52.20, even though the company printed another quarter of solid oncology profits. Q2 revenue came in at about US$628.7 million and net income reached roughly US$212 million, keeping the cabozantinib cash engine firmly running. The tension for you now is time horizon. Short term traders are reacting to the trimmed full year revenue guidance. Long term holders will be looking at the higher net profit margin and...

Corteva, Inc. recently reported second-quarter 2026 results showing sales of US$6,379 million and net income of US$1,161 million, alongside affirming a US$0.18 per-share dividend for payment on September 15, 2026. Despite year-on-year declines in quarterly sales and earnings, management raised full-year 2026 operating EPS guidance to US$3.60–US$3.80, indicating confidence based on strong execution in the first half. We’ll now explore how Corteva’s higher full-year operating EPS guidance...

Magnite stock ripped higher today, jumping 17.7% to US$24.32, as investors rushed to reprice a business that has just put up one of its cleanest profit stories in years. The headline is simple: advertising dollars in connected TV are flowing through Magnite’s pipes with increasing efficiency, and that is now showing clearly in the margin line. Q2 revenue came in at US$192.8m. The sharper signal was profitability, with net income of US$19.4m and adjusted earnings power underpinned by strong...

Inspired Entertainment holders watched the stock fall 4.8% today to US$6.62, capping a tough three months, yet the earnings story behind that move is more nuanced. The headline is margin power. Q2 revenue came in around US$61 million, but the key detail was an adjusted earnings before interest, tax, depreciation and amortization margin near 45% and guidance for US$112 million to US$118 million of adjusted EBITDA for 2026. The market appears focused on the price slide, while the fundamentals...

Arcosa stock barely flinched after earnings, slipping about 0.3% despite a quarter that put profit trends front and center. The market treated the print as routine. The income statement did not. The headline is earnings power. Second quarter basic earnings per share came in around US$1.04 on revenue of about US$658.7 million, with net income excluding extra items of US$50.9 million. On a trailing twelve month view, Arcosa shows US$220.1 million of net income excluding extra items. That is the...

Veeco Instruments came into this print as a high expectations semiconductor equipment stock, priced on a rich story and a rich P/E. The stock slipped about 3% today despite a Q2 headline that many investors would usually cheer. Revenue landed at about US$193 million with non GAAP operating income of US$23 million and non GAAP EPS of US$0.33, all paired with a raised full year outlook. That creates a clear expectation gap. The earnings looked solid on the surface while the share price reaction...

Paysign arrived into this earnings print already on a tear, with the stock almost doubling over the last three months, then jumped another 29.3% today to close at US$12.40. That kind of move usually signals either a short squeeze or a thesis reset. In this case, it is the market reacting to one clear headline. The payments and patient affordability specialist just delivered a Q2 that put profitability at the center of the story. Revenue reached US$28.3m while net income excluding extra items...

Xencor stock barely flinched after earnings, ticking up less than 1% even as the quarter rewired the story around its income statement. The headline for Q2 is simple: revenue landed at US$51.2m while the company still reported a sizeable net loss of US$21.7m. For a clinical stage biotech, that mix of meaningful revenue and ongoing losses forces investors to decide whether today’s muted move reflects calm judgment or a market that is reluctant to reprice the stock until the profitability path...

Klaviyo came into this print as a fast growing marketing automation stock with a reputation for pairing software scale with improving profitability. The market looked past that on the day. The share price fell about 13% to US$16.73 after the Q2 release. The headline is simple. Revenue reached US$370.6m while non GAAP operating income landed at US$50.9m. Management raised full year revenue guidance but trimmed the profit outlook as it leans harder into product and the Agency acquisition. The...

DoorDash stock pushed 2.9% higher to about US$213 today, which is a punchy move for a company already trading on a rich P/E multiple. The market is cheering one thing above all else: revenue for Q2 came in at US$4.5b with net income of US$200m, which keeps the profit story alive even as investors debate how much to pay for it. The emotional tug of war is clear. A high growth profile meets an expensive stock, and today buyers are acting as if the earnings headline just validated paying up. The...

Biodesix stock slipped almost 3% to US$22.10 today, even though the earnings story was less gloomy than the price move suggests. Coming into the print, shares had run hard over the past three months. That set the stage for a sentiment check once the numbers hit. The headline from Q2 is simple. Biodesix is still loss making, yet revenue reached US$26.9m and the net loss narrowed to US$7.3m. Gross margin held at a high 82%. The market focused on the red ink. The results pointed to a cleaner...

T1 Energy Inc. recently announced a contract to supply Clearway Energy Group with 641 MW of solar modules using domestic cells from its G2_Austin facility, advancing its efforts to build a traceable U.S.-based solar supply chain. This deal highlights how rising interest in domestic content and tariff resilience is directly feeding into long-term manufacturing and offtake commitments for T1. We’ll now examine how this large Clearway domestic-content contract may influence T1 Energy’s...

Joby Aviation stock jumped about 6% today, yet the earnings story is far less euphoric than the price move suggests. The real headline is a widening loss alongside rapid early revenue build in an electric air taxi business that is still pre commercial. Q2 revenue reached about US$38.6 million, helped by the Blade acquisition, while the GAAP net loss deepened to roughly US$245 million as cash use stepped up to fund certification and production. The market is cheering progress, but the balance...

Buybacks, cash, and a new CEO put Berkshire Hathaway in focus Berkshire Hathaway (BRK.A) has drawn fresh attention after stepping up share repurchases in the second quarter while still sitting on a sizable cash pile under new CEO Greg Abel. See our latest analysis for Berkshire Hathaway. Over the past year Berkshire Hathaway’s share price return has been supported by steady gains, including a 9.56% 90 day share price return and a 12.29% 1 year total shareholder return, which points to...

The market loved Mativ Holdings on impact. The stock jumped 22% to $11.68, capping a strong run over the past month, while the earnings story was far more about balance sheet relief than a simple quarterly beat. Q2 brought US$75m of adjusted EBITDA and US$60m of free cash flow, which helped pull net leverage down to 3.8x. That debt progress is what traders are reacting to. The question for you is whether this sharp repricing matches the pace of fundamental repair or reflects relief that the...

OTC Markets Group stock inched up 1.7% to about US$55.95 after earnings, a calm reaction to what was effectively a margin story. The company leans on a reputation as a steady, cash generative market operator. This quarter the headline is firm profitability with expanding operating muscle. Revenue for Q2 2026 came in around US$30.6m while basic earnings per share reached about US$0.72. Operating income and adjusted earnings before interest, tax, depreciation and amortization both pointed to a...

Axon Enterprise walked into this quarter priced as a high growth public safety platform, and walked out with the stock down 14.3% in a single session. That kind of hit grabs attention, especially after a roughly flat week and a 30 day slide. The headlines behind that move are blunt. Axon reported Q2 2026 revenue of US$904.4m and basic earnings per share of US$0.37, with investors zeroing in on the pressure in quarterly profit versus recent history. Is Axon Enterprise now priced as a growth...

Atmos Energy stock barely flinched after earnings, slipping only 0.2% to about US$171. That muted move stands in sharp contrast to the scale of what just hit the tape. Fiscal year to date, Atmos Energy has already delivered US$1.2b in net income and US$7.33 in diluted EPS, and management is keeping full year EPS guidance intact at US$8.40 to US$8.50. Short term traders saw a flat chart. Long term investors saw a regulated gas utility committing roughly US$4.2b of capital this year and...

Immunocore Holdings plc has reported its Q2 2026 and half-year results, with Q2 revenue rising to US$115.93 million and the quarterly net loss narrowing to US$0.81 million, while the first half of 2026 showed revenue of US$222.60 million and net income of US$12.16 million. The shift from a loss in the prior-year period to positive earnings over the first six months, alongside lower per-share losses in Q2, may influence how investors assess Immunocore’s progress toward more consistent...

BillionToOne stock just absorbed a brutal shock. Shares closed at about US$91.56 after earnings, down almost 39% from the prior US$149.97 close, even though the company stayed in the black. Q2 basic earnings per share landed at US$0.17 on revenue of US$109.45m. For short term traders, the move is already in the rearview mirror. For anyone thinking in years rather than hours, the bigger story is that BillionToOne has only recently turned profitable and still carries a rich P/E multiple on...

Deluxe came into this earnings day with the stock quietly grinding higher over the past month, then slipped about 2% to US$26.11 once investors saw the numbers. The reputation is old world checks and print, but the headline from this quarter is very different. The story sits in profitability, not nostalgia, with adjusted EBITDA for the first half of 2026 higher year to date and free cash flow of US$85.9m giving Deluxe more room to chip away at debt. Is Deluxe really as cheap as its 11.9x P/E...

Zevia PBC stock just sank 13.5% to about US$1.48, even though the headline from this quarter was not a collapse in sales. The real story was a squeeze in profitability that kept the market on edge. Net sales for the quarter sat at US$45.0m, but earnings per share stayed in loss territory and investors reacted fast. Step back from today’s price drop and a different picture starts to form. Zevia is still growing its trailing twelve month revenue and has been narrowing losses over several years...

U.S. Physical Therapy shares slipped about 1.5% today, yet the earnings story reads more like a sharp reset than a setback. After two loss making quarters, the company swung back to profit in Q2 with basic earnings per share of US$0.66 and net income of US$9.9m on revenue of US$211.9m. For a stock that has climbed strongly over the past three months and still carries a very high trailing P/E, the modest pullback suggests investors are wrestling with how durable this profit recovery really...